Tempest Therapeutics, Inc.·4

Oct 13, 4:39 PM ET

Whiting Samuel 4

4 · Tempest Therapeutics, Inc. · Filed Oct 13, 2023

Insider Transaction Report

Form 4
Period: 2023-10-11
Whiting Samuel
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-10-11+325,000325,000 total
    Exercise: $9.77Exp: 2033-10-10Common Stock (325,000 underlying)
Footnotes (1)
  • [F1]25% of the award shall vest on October 11, 2024 and the remainder of the award shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION